Alterations of NK Cell Phenotype During Pregnancy in Multiple Sclerosis.

CD56 Antigen / metabolism Cohort Studies Female Humans Killer Cells, Natural / metabolism Multiple Sclerosis / metabolism Phenotype Pregnancy
FlowSOM clustering immune profiling immune tolerance multiple sclerosis natural killer cells pregnancy

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 30 03 2022
accepted: 30 05 2022
entrez: 21 7 2022
pubmed: 22 7 2022
medline: 23 7 2022
Statut: epublish

Résumé

In multiple sclerosis (MS), relapse rate is decreased by 70-80% in the third trimester of pregnancy. However, the underlying mechanisms driving this effect are poorly understood. Evidence suggests that CD56

Identifiants

DOI: 10.3389/fimmu.2022.907994 PMID: 35860238 PMC: PMC9289470
pubmed: 35860238
doi: 10.3389/fimmu.2022.907994
pmc: PMC9289470
doi:

Substances chimiques

CD56 Antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

907994

Informations de copyright

Copyright © 2022 Wisgalla, Ramien, Streitz, Schlickeiser, Lupu, Diemert, Tolosa, Arck, Bellmann-Strobl, Siebert, Heesen, Paul, Friese, Infante-Duarte and Gold.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell Rep. 2019 Oct 22;29(4):810-815.e4
pubmed: 31644905
Proc Natl Acad Sci U S A. 2010 May 18;107(20):9299-304
pubmed: 20439708
Bioessays. 2019 Sep;41(9):e1900072
pubmed: 31373044
Front Immunol. 2019 Oct 23;10:2469
pubmed: 31708922
Immunity. 2017 Nov 21;47(5):820-833
pubmed: 29166586
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Cell Immunol. 1997 Jun 15;178(2):108-16
pubmed: 9225001
J Reprod Immunol. 1987 Jun;11(2):135-45
pubmed: 3625609
J Immunol. 2008 Apr 15;180(8):5746-53
pubmed: 18390760
J Clin Immunol. 2012 Apr;32(2):300-11
pubmed: 22198680
Clin Immunol. 2011 Dec;141(3):348-56
pubmed: 21992960
Neurotherapeutics. 2021 Jul;18(3):1783-1797
pubmed: 34244929
Front Immunol. 2013 Mar 13;4:63
pubmed: 23493880
Semin Immunopathol. 2016 Nov;38(6):709-718
pubmed: 27501960
Eur J Immunol. 2001 Jun;31(6):1656-65
pubmed: 11385609
Neuroimage. 2012 Feb 15;59(4):3774-83
pubmed: 22119648
Clin Exp Immunol. 2008 Feb;151(2):235-43
pubmed: 18062798
Science. 1999 Feb 26;283(5406):1277-8
pubmed: 10084932
Science. 2011 Jan 7;331(6013):44-9
pubmed: 21212348
Blood. 2007 Jul 15;110(2):606-15
pubmed: 17405908
FASEB J. 2005 Nov;19(13):1902-4
pubmed: 16144955
Front Immunol. 2021 Jan 28;11:552101
pubmed: 33584638
J Immunol. 2019 Oct 1;203(7):1743-1752
pubmed: 31444265
Front Immunol. 2019 Aug 16;10:1935
pubmed: 31474999
Trends Immunol. 2006 Sep;27(9):399-404
pubmed: 16843067
Am J Reprod Immunol. 2010 Jun;63(6):425-33
pubmed: 20367629
Lancet Neurol. 2016 Jan;15(1):35-46
pubmed: 26621682
BJOG. 2011 Jun;118(7):790-7
pubmed: 21401856
Blood Adv. 2020 Apr 14;4(7):1388-1406
pubmed: 32271902
PLoS One. 2012;7(2):e31959
pubmed: 22384114
Blood. 2008 Aug 1;112(3):461-9
pubmed: 18650461
Int Immunopharmacol. 2007 Dec 15;7(13):1765-75
pubmed: 17996687
Cancer Immunol Immunother. 2011 Dec;60(12):1683-95
pubmed: 21706285
J Reprod Immunol. 2013 Mar;97(1):140-6
pubmed: 23432880
J Neuroimmunol. 2003 Dec;145(1-2):103-14
pubmed: 14644036
Front Immunol. 2017 Feb 23;8:196
pubmed: 28280497
J Immunol. 2011 Jun 15;186(12):6753-61
pubmed: 21555534
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14506-11
pubmed: 25246558
Trends Immunol. 2009 Apr;30(4):143-9
pubmed: 19282243
Sci Rep. 2015 Sep 22;5:13618
pubmed: 26391604
Fertil Steril. 2002 May;77(5):1032-7
pubmed: 12009363
Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2973-82
pubmed: 27162345
Mult Scler. 2014 Jun;20(7):790-801
pubmed: 24144875
Eur J Immunol. 2018 Feb;48(2):380-383
pubmed: 29108094
Biosci Biotechnol Biochem. 2006 Jan;70(1):47-53
pubmed: 16428820
Eur J Immunol. 2003 Jun;33(6):1657-66
pubmed: 12778484
Cell. 2012 Jul 6;150(1):29-38
pubmed: 22770213
Horm Behav. 2012 Aug;62(3):263-71
pubmed: 22406114
J Autoimmun. 2012 May;38(2-3):J103-8
pubmed: 22004905
J Autoimmun. 2016 Aug;72:8-18
pubmed: 27157273
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
Front Immunol. 2016 Dec 19;7:606
pubmed: 28066417
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6
pubmed: 16585503
N Engl J Med. 1998 Jul 30;339(5):285-91
pubmed: 9682040

Auteurs

Anne Wisgalla (A)

Medizinische Klinik m.S. Psychosomatik, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Charité-Universitätsmedizin Berlin, Berlin, Germany.

Caren Ramien (C)

Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Mathias Streitz (M)

Institut für Medizinische Immunologie, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
BIH Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.

Stephan Schlickeiser (S)

Institut für Medizinische Immunologie, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
BIH Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.

Andreea-Roxana Lupu (AR)

Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania.

Anke Diemert (A)

Klinik für Geburtshilfe und Pränatalmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Eva Tolosa (E)

Institut für Immunologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Petra C Arck (PC)

Klinik für Geburtshilfe und Pränatalmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Judith Bellmann-Strobl (J)

Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Charité-Universitätsmedizin Berlin, Berlin, Germany.
NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Nadja Siebert (N)

Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Charité-Universitätsmedizin Berlin, Berlin, Germany.

Christoph Heesen (C)

Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Friedemann Paul (F)

Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Charité-Universitätsmedizin Berlin, Berlin, Germany.
NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Manuel A Friese (MA)

Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Carmen Infante-Duarte (C)

Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Charité-Universitätsmedizin Berlin, Berlin, Germany.

Stefan M Gold (SM)

Medizinische Klinik m.S. Psychosomatik, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Klinik für Psychiatrie und Psychotherapie, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes de différenciation des lymphocytes T › Antigènes CD56 › Alterations of NK Cell Phenotype During...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Alterations of NK Cell Phenotype During...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Alterations of NK Cell Phenotype During...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Cellules tueuses naturelles › Alterations of NK Cell Phenotype During...
questionsmedicales.fr › Maladies du système immunitaire › Maladies auto-immunes › Maladies auto-immunes du système nerveux › Maladies démyélinisantes auto-immunes du SNC › Sclérose en plaques › Alterations of NK Cell Phenotype During...
questionsmedicales.fr › Phénomènes génétiques › Phénotype › Alterations of NK Cell Phenotype During...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Alterations of NK Cell Phenotype During...